Joel M Phelps, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Mary Street, Evansville, IN 47747 Phone: 812-450-3036 Fax: 812-450-2193 |
Jessica Watson, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 415 W Columbia St Ste 110, Evansville, IN 47710 Phone: 812-450-3363 |
Dr. Roy Allen Defries, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3524 N 1st Ave, Evansville, IN 47710 Phone: 812-425-1555 Fax: 812-425-1815 |
Cynthia Marks, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4912 University Dr, Evansville, IN 47712 Phone: 812-428-2273 |
Richard A Riedford, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 8600 University Blvd, Rm Hp0091, Evansville, IN 47712 Phone: 812-465-1250 Fax: 812-465-7170 |
David E Schultz Ii, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1231 Washington Sq, Evansville, IN 47715 Phone: 812-479-6907 Fax: 812-479-6967 |
Dr. Harry Oliver Stoutland, M. D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1800 W Summit Dr, Evansville, IN 47712 Phone: 812-985-0144 |
Michael R Hobson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 Mary St, Evansville, IN 47747 Phone: 812-450-7338 Fax: 812-450-2193 |
Tiffany Frey, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 415 W Columbia St Ste 110, Evansville, IN 47710 Phone: 812-450-3363 Fax: 812-450-3071 |
Ms. Shalonda Maree Newcomb, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 15814 Neeley St, Evansville, IN 47725 Phone: 812-867-8991 Fax: 812-867-8995 |
Daniel Holland, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 415 W Columbia St, Suite 110, Evansville, IN 47710 Phone: 812-450-3363 Fax: 812-450-3071 |
Dr. William Jay Tuley, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1200 Professional Blvd, Evansville, IN 47714 Phone: 812-479-9500 Fax: 812-437-0037 |
Dr. William A. Blume, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4501 N 4th Ave, Evansville, IN 47710 Phone: 812-422-7212 Fax: 812-422-7326 |
Mrs. Amanda Jean Orr, FNP-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1909 W Franklin St, Evansville, IN 47712 Phone: 812-456-9736 Fax: 812-456-0140 |
Krishna Chilikuri, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 515 Read St, Evansville, IN 47710 Phone: 812-450-3363 Fax: 812-450-3071 |
Dr. Charles A Strickland, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 415 W Columbia St, Ste 110, Evansville, IN 47710 Phone: 812-450-3363 Fax: 812-450-3071 |
Akitto Ledda, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4506 1st Ave, Evansville, IN 47710 Phone: 812-428-6161 Fax: 812-421-2883 |
Jared Hutson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 415 W Columbia St Ste 110, Evansville, IN 47710 Phone: 812-450-3363 Fax: 812-450-3071 |
News Archive
Three products for patients with end stage renal disease (ESRD) have been chosen to participate in the FDA's Innovation Pathway, an evolving system designed to help medical devices reach patients in a safe, timely and collaborative manner.
Galderma Laboratories, L.P. announced that the U.S. Food and Drug Administration has approved Mirvaso (brimonidine) topical gel, 0.33% for the topical treatment of the facial erythema (redness) of rosacea in adults 18 years of age or older. Applied once daily, Mirvaso works quickly to reduce the redness of rosacea and lasts up to 12 hours. Galderma expects Mirvaso to be available in pharmacies September 2013.
"Countries with the highest numbers of malnourished children urgently need to step up the way they respond to the problem in order to prevent millions of unnecessary deaths, according to a joint report," titled the "Nutrition Barometer" and released on Friday by Save the Children and World Vision, AlertNet reports.
Sanofi-aventis announced today the results from the two year phase III TEMSO study of teriflunomide, a novel oral disease modifier investigated for the treatment of relapsing multiple sclerosis (RMS).
New technologies and ingredients are improving the taste, appearance and nutritional content of gluten-free food products, a market that is expected to grow to $6 billion by 2017, according to a presentation today at the 2013 Institute of Food Technologists (IFT) Annual Meeting & Food Expo- in Chicago.
› Verified 4 days ago